HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Threat Of Adulteration For Profit Grows With Globalization Of Supply Chain

This article was originally published in The Tan Sheet

Executive Summary

Deliberate adulteration of dietary supplements for economic gain is a growing threat that FDA and the food and drug industries must work together to neutralize, according to the agency's food safety chief and a trade group executive

You may also be interested in...

CDER Enforcement Priorities Include Quality Control, Drug "Criminalization"

FDA's Center for Drug Evaluation and Research will crack down on manufacturers that attempt to "farm out responsibility," firms that fail to meet reporting requirements and the general "criminalization of our drug supply," said Deb Autor, director of the center's compliance office

Country Of Origin Labeling Could Confuse Consumers, Increase OTC Costs

Country-of-origin labeling for drugs could drive OTC manufacturing costs up and confuse consumers with unnecessary information on labels, industry stakeholders say

Supplements Spared From Melamine “Bombs” – So Far, UNPA’s Israelsen Says

The dietary supplement industry has "been lucky," dodging a serious adulteration problem like the melamine contamination that has plagued pet food and infant formula businesses, Loren Israelsen says

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts